NACL Industries Limited announced that the Board of Directors in its meeting held on July 27, 2023 approved the Company's plan to expand its business portfolio with entry into Specialty Materials and Intermediates (including Fluorinated compounds), Specialty Nutrition and Bioproducts, addressing Agriculture, Healthcare, Industrial and other sectors. The Company envisages an investment of about INR 1,000 million over the next three years for the said businesses including expansion of its existing Manufacturing and R&D facilities for captive as well as Custom Development and Contract Manufacturing opportunities.